Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation

American Journal of Cardiology

Volumn 112, Issue 4, 2013, Pages 513-519

  Canpolat, Uǧur ^a   Aytemir, Kudret ^a   Yorgun, Hikmet ^a   Şahiner, Levent ^a   Kaya, Ergün Bariş ^a   Kabakçi, Giray ^a   Tokgözoǧlu, Lale ^a   Oto, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CATHETER ABLATION; CELLULAR PARAMETERS; CLINICAL TRIAL; CRYOABLATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTICOAGULANTS; AREA UNDER CURVE; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; COMORBIDITY; CRYOSURGERY; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RECURRENCE; REGRESSION ANALYSIS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84881132741     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.04.015     Document Type: Article

References (24)

1. M. Haissaguerre, P. Jais, D.C. Shah, A. Takahashi, M. Hocini, G. Quiniou, S. Garrigue, A. Le Mouroux, P. Le Metayer, and J. Clementy Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 339 1998 659 666
2. H. Calkins, M.R. Reynolds, P. Spector, M. Sondhi, Y. Xu, A. Martin, C.J. Williams, and I. Sledge Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses Circ Arrhythm Electrophysiol 2 2009 349 361
3. D.J. Wilber, C. Pappone, P. Neuzil, A. De Paola, F. Marchlinski, A. Natale, L. Macle, E.G. Daoud, H. Calkins, B. Hall, V. Reddy, G. Augello, M.R. Reynolds, C. Vinekar, C.Y. Liu, S.M. Berry, and D.A. Berry Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial JAMA 303 2010 333 340
4. O.M. Wazni, N.F. Marrouche, D.O. Martin, A. Verma, M. Bhargava, W. Saliba, D. Bash, R. Schweikert, J. Brachmann, J. Gunther, K. Gutleben, E. Pisano, D. Potenza, R. Fanelli, A. Raviele, S. Themistoclakis, A. Rossillo, A. Bonso, and A. Natale Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial JAMA 293 2005 2634 2640
5. A.J. Camm, G.Y. Lip, R. De Caterina, I. Savelieva, D. Atar, S.H. Hohnloser, G. Hindricks, P. Kirchhof ESC Committee for Practice Guidelines-CPG; Document Reviewers 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association Europace 14 2012 1385 1413
6. J. Vogt, J. Heintze, K.J. Gutleben, B. Muntean, D. Horstkotte, and G. Nolker Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients J Am Coll Cardiol 61 2012 1707 1712
7. H. Calkins, K.H. Kuck, R. Cappato, J. Brugada, A.J. Camm, S.A. Chen, H.J. Crijns, R.J. Damiano Jr., D.W. Davies, J. DiMarco, J. Edgerton, K. Ellenbogen, M.D. Ezekowitz, D.E. Haines, M. Haissaguerre, G. Hindricks, Y. Iesaka, W. Jackman, J. Jalife, P. Jais, J. Kalman, D. Keane, Y.H. Kim, P. Kirchhof, G. Klein, H. Kottkamp, K. Kumagai, B.D. Lindsay, M. Mansour, F.E. Marchlinski, P.M. McCarthy, J.L. Mont, F. Morady, K. Nademanee, H. Nakagawa, A. Natale, S. Nattel, D.L. Packer, C. Pappone, E. Prystowsky, A. Raviele, V. Reddy, J.N. Ruskin, R.J. Shemin, H.M. Tsao, D. Wilber Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society Heart Rhythm 9 2012 632 696.e621
8. K.P. Letsas, R. Weber, G. Burkle, C.C. Mihas, J. Minners, D. Kalusche, and T. Arentz Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation Europace 11 2009 158 163
9. M. Rotter, P. Jais, M.C. Vergnes, P. Nurden, Y. Takahashi, P. Sanders, T. Rostock, M. Hocini, F. Sacher, and M. Haissaguerre Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation J Am Coll Cardiol 47 2006 1231 1233
10. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, I.C. Van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S.H. Hohloser, P. Kolh, J.Y. Le Heuzey, P. Ponikowski, F.H. Rutten, A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, P.E. Vardas, P. Widimsky, V. Agladze, E. Aliot, T. Balabanski, C. Blomstrom-Lundqvist, A. Capucci, H. Crijns, B. Dahlof, T. Folliguet, M. Glikson, M. Goethals, D.C. Gulba, S.Y. Ho, R.J. Klautz, S. Kose, J. McMurray, P. Perrone Filardi, P. Raatikainen, M.J. Salvador, M.J. Schalij, A. Shpektor, J. Sousa, J. Stepinska, H. Uuetoa, J.L. Zamorano, and I. Zupan Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 2010 1360 1420
11. M.C. Chen, J.P. Chang, W.H. Liu, C.H. Yang, Y.L. Chen, T.H. Tsai, Y.H. Wang, and K.L. Pan Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation Am J Cardiol 102 2008 861 865
12. T. Yamashita, A. Sekiguchi, Y.K. Iwasaki, T. Date, K. Sagara, H. Tanabe, H. Suma, H. Sawada, and T. Aizawa Recruitment of immune cells across atrial endocardium in human atrial fibrillation Circ J 74 2010 262 270
13. A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M.A. Russo, and A. Maseri Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
14. B. Ramlawi, H. Otu, S. Mieno, M. Boodhwani, N.R. Sodha, R.T. Clements, C. Bianchi, and F.W. Sellke Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study Ann Thorac Surg 84 2007 1166 1172 discussion 1172-1173
15. P.H. Gibson, B.H. Cuthbertson, B.L. Croal, D. Rae, H. El-Shafei, G. Gibson, R.R. Jeffrey, K.G. Buchan, and G.S. Hillis Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting Am J Cardiol 105 2010 186 191
16. Y. Nakamura, K. Nakamura, K. Fukushima-Kusano, K. Ohta, H. Matsubara, T. Hamuro, C. Yutani, and T. Ohe Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis Thromb Res 111 2003 137 142
17. T. Bhat, S. Teli, J. Rijal, H. Bhat, M. Raza, G. Khoueiry, M. Meghani, M. Akhtar, and T. Costantino Neutrophil to lymphocyte ratio and cardiovascular diseases: a review Expert Rev Cardiovasc Ther 11 2013 55 59
18. A. Aribas, H. Akilli, E.E. Gul, M. Kayrak, K. Demir, C. Duman, H. Alibasic, M. Yazici, K. Ozdemir, and H. Gok Can neutrophil/lymphocyte ratio predict recurrence after electrical cardioversion in non-valvular atrial fibrillation? Anadolu Kardiyol Derg 13 2013 123 130
19. J.G. Andrade, P. Khairy, P.G. Guerra, M.W. Deyell, L. Rivard, L. Macle, B. Thibault, M. Talajic, D. Roy, and M. Dubuc Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies Heart Rhythm 8 2011 1444 1451
20. D'Ascenzo F, Corleto A, Biondi-Zoccai G, Anselmino M, Ferraris F, di Biase L, Natale A, Hunter RJ, Schilling RJ, Miyazaki S, Tada H, Aonuma K, Yenn-Jiang L, Tao H, Ma C, Packer D, Hammill S, Gaita F. Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis. Int J Cardiol Epub 2012 May 12.
21. J.M. McCabe, L.M. Smith, Z.H. Tseng, N. Badhwar, B.K. Lee, R.J. Lee, M.M. Scheinman, J.E. Olgin, and G.M. Marcus Protracted CRP elevation after atrial fibrillation ablation Pacing Clin Electrophysiol 31 2008 1146 1151
22. N. Lellouche, F. Sacher, M. Wright, I. Nault, J. Brottier, S. Knecht, S. Matsuo, O. Lomas, M. Hocini, M. Haissaguerre, and P. Jais Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation Europace 11 2009 662 664
23. T. Koyama, Y. Sekiguchi, H. Tada, T. Arimoto, H. Yamasaki, K. Kuroki, T. Machino, K. Tajiri, X.D. Zhu, M. Kanemoto, A. Sugiyasu, K. Kuga, and K. Aonuma Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation Am J Cardiol 103 2009 1249 1254
24. J. Kornej, C. Reinhardt, J. Kosiuk, A. Arya, G. Hindricks, V. Adams, D. Husser, and A. Bollmann Response of high-sensitive C-reactive protein to catheter ablation of atrial fibrillation and its relation with rhythm outcome PLoS One 7 2012 e44165